Intrexon Corp (XON)

19.14
0.21 1.11
NYSE : Health Care
Prev Close 18.93
Open 18.93
Day Low/High 18.78 / 19.35
52 Wk Low/High 18.55 / 38.60
Volume 715.45K
Avg Volume 1.33M
Exchange NYSE
Shares Outstanding 118.73M
Market Cap 2.28B
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Shell Deal Hands Biggest U.S. Oil Refinery to Saudi Aramco

Shell Deal Hands Biggest U.S. Oil Refinery to Saudi Aramco

Saudi Aramco will assume control of the biggest oil refinery in the U.S. after a $2.2 billion deal with Shell that exits a joint venture in Port Arthur, Texas.

XON: Insiders vs. Shorts

XON: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/31/2017 settlement date, and Intrexon Corp is one of the most shorted stocks of the Russell 3000, based on 11.99 "days to cover" versus the median component at 5.13. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Noteworthy Thursday Option Activity: XON, PBYI, KPTI

Noteworthy Thursday Option Activity: XON, PBYI, KPTI

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Intrexon Corp , where a total of 12,560 contracts have traded so far, representing approximately 1.3 million underlying shares. That amounts to about 99.4% of XON's average daily trading volume over the past month of 1.3 million shares.

5 Stocks Setting Up for Big Breakouts

5 Stocks Setting Up for Big Breakouts

Here's how to rake in the gains off some potential big breakouts.

Intrexon To Acquire GenVec To Expand Industry-Leading Gene Delivery Platform

Intrexon To Acquire GenVec To Expand Industry-Leading Gene Delivery Platform

GenVec's AdenoVerse™ to be Integrated into Intrexon's Proprietary Synthetic Biology Platform

Allergan, Apple, Facebook: Doug Kass' Views

Allergan, Apple, Facebook: Doug Kass' Views

Doug Kass shares his thoughts on buying retail, and discusses why he's favoring the short side in a big way.

Oragenics Shareholder Update

Oragenics Shareholder Update

Oragenics, Inc. (NYSE MKT:OGEN.

Starbucks, Allergan, Amazon: Doug Kass' Views

Starbucks, Allergan, Amazon: Doug Kass' Views

Doug Kass shares his thoughts on how 2017 will be the year of 'the Dude.'

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies -- including Medtronic and Medicines -- have been scooping up shares of their own stock lately.

Oragenics Presents Engineering Of Improved Lantibiotic Variants At American Society For Microbiology (ASM) Conference On Antibacterial Development

Oragenics Presents Engineering Of Improved Lantibiotic Variants At American Society For Microbiology (ASM) Conference On Antibacterial Development

Oragenics (NYSE MKT:OGEN.BC), a leader in the development of new antibiotics against infectious disease and developing effective treatments for oral mucositis, today announced it presented at the American Society for...

Synthetic Biologics Announces Granting Of U.S. Composition Of Matter Patent For SYN-005, Designed For The Treatment And Prevention Of Pertussis (Whooping Cough)

Synthetic Biologics Announces Granting Of U.S. Composition Of Matter Patent For SYN-005, Designed For The Treatment And Prevention Of Pertussis (Whooping Cough)

- Granted Patent Provides Composition of Matter Protection for SYN-005 to at Least 2035 -

Beware the Fear of Missing Out (FOMO)

Beware the Fear of Missing Out (FOMO)

There's a striking lack of volatility, and that's a flashing red warning signal.

Facebook, Apple, Starbucks: Doug Kass' Views

Facebook, Apple, Starbucks: Doug Kass' Views

Doug Kass shares his thoughts on managing and selecting short-term trades.

XON: Insiders vs. Shorts

XON: Insiders vs. Shorts

The most recent short interest data was recently released for the 11/15/2016 settlement date, and Intrexon Corp is one of the most shorted stocks of the Russell 3000, based on 12.58 "days to cover" versus the median component at 4.41. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Apple, Starbucks, Cisco: Doug Kass' Views

Apple, Starbucks, Cisco: Doug Kass' Views

Doug Kass shares his thoughts on a strange, possibly ominous day, and a 'ludicrous forecast.'

Oxitec Announces Friendly™ Aedes Project Is Supported By 92.8% Of Piracicaba's Population

Oxitec Announces Friendly™ Aedes Project Is Supported By 92.8% Of Piracicaba's Population

Genetically engineered mosquito that fights Aedes aegypti achieves high approval rate among residents of city where it is applied